These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31759244)

  • 1. Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.
    Burgaña A; Abellana R; Yordanov SZ; Kazan R; Pérez Ortiz AM; Ramos CC; Hernández CG; Rivero MM; Gonçalves AQ; Padilla E; Pérez J; García-Puig R; Perez-Porcuna TM
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():95-100. PubMed ID: 31759244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical characteristics of Dientamoeba fragilis infection.
    Menéndez C; Fernández-Suarez J; Boga Ribeiro JA; Rodríguez-Pérez M; Vázquez F; Gonzalez-Sotorrios N; Rodríguez-Guardado A
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37(5):290-295. PubMed ID: 30274823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment.
    Clemente L; Pasut M; Carlet R; Ruscio M; Fontana F
    Parasitol Int; 2021 Feb; 80():102227. PubMed ID: 33137500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection?
    Boga JA; Rojo S; Fernández J; Rodríguez M; Iglesias C; Martínez-Camblor P; Vázquez F; Rodríguez-Guardado A
    Int J Infect Dis; 2016 Aug; 49():59-61. PubMed ID: 27263118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-controlled study of Dientamoeba fragilis infections in children.
    Banik GR; Barratt JL; Marriott D; Harkness J; Ellis JT; Stark D
    Parasitology; 2011 Jun; 138(7):819-23. PubMed ID: 21524324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and treatment of Dientamoeba fragilis infection in children, a retrospective study.
    Schure JM; de Vries M; Weel JF; van Roon EN; Faber TE
    Pediatr Infect Dis J; 2013 Apr; 32(4):e148-50. PubMed ID: 23190787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Dientamoeba fragilis infection with paromomycin.
    Vandenberg O; Souayah H; Mouchet F; Dediste A; van Gool T
    Pediatr Infect Dis J; 2007 Jan; 26(1):88-90. PubMed ID: 17195717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children].
    Bosman DK; Benninga MA; van de Berg P; Kooijman GC; van Gool T
    Ned Tijdschr Geneeskd; 2004 Mar; 148(12):575-9. PubMed ID: 15074181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dientamoeba fragilis: initial evidence of pathogenicity in the western lowland gorilla (Gorilla gorilla gorilla).
    Lankester F; Kiyang JA; Bailey W; Unwin S
    J Zoo Wildl Med; 2010 Jun; 41(2):350-2. PubMed ID: 20597233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole.
    Girginkardeşler N; Coşkun S; Cüneyt Balcioğlu I; Ertan P; Ok UZ
    Clin Microbiol Infect; 2003 Feb; 9(2):110-3. PubMed ID: 12588330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dientamoeba fragilis and chronic abdominal pain in children: a case-control study.
    de Jong MJ; Korterink JJ; Benninga MA; Hilbink M; Widdershoven J; Deckers-Kocken JM
    Arch Dis Child; 2014 Dec; 99(12):1109-13. PubMed ID: 25053737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.
    Engsbro AL; Stensvold CR; Nielsen HV; Bytzer P
    Am J Trop Med Hyg; 2012 Dec; 87(6):1046-52. PubMed ID: 23091195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of Dientamoeba fragilis.
    Nagata N; Marriott D; Harkness J; Ellis JT; Stark D
    Antimicrob Agents Chemother; 2012 Jan; 56(1):487-94. PubMed ID: 22024820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis.
    Kurt O; Girginkardeşler N; Balcioğlu IC; Ozbilgin A; Ok UZ
    Clin Microbiol Infect; 2008 Jun; 14(6):601-4. PubMed ID: 18397330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dientamoeba fragilis infection as cause of severe abdominal discomfort and flatulence].
    Halkjær S; Stensvold CR; Petersen AM
    Ugeskr Laeger; 2015 Jan; 177(2A):30-1. PubMed ID: 25612954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole.
    Chan FT; Guan MX; Mackenzie AM; Diaz-Mitoma F
    Antimicrob Agents Chemother; 1994 May; 38(5):1157-60. PubMed ID: 8067755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical guideline on Dientamoeba fragilis infections.
    van Gestel RS; Kusters JG; Monkelbaan JF
    Parasitology; 2019 Aug; 146(9):1131-1139. PubMed ID: 30165915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the clinical presentation of dientamoebiasis.
    Stark D; Barratt J; Roberts T; Marriott D; Harkness J; Ellis J
    Am J Trop Med Hyg; 2010 Apr; 82(4):614-9. PubMed ID: 20348509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Dientamoeba fragilis Prevalence and Evaluation of Sociodemographic and Clinical Features in Patients with Gastrointestinal Symptoms.
    Aykur M; Calıskan Kurt C; Dirim Erdogan D; Biray Avcı C; Vardar R; Aydemir S; Girginkardeşler N; Gündüz C; Dagci H
    Acta Parasitol; 2019 Mar; 64(1):162-170. PubMed ID: 30645736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dientamoeba fragilis in children: a systematic review on diagnostic considerations and efficacy of treatment.
    van Kalleveen MW; van Gool T; Klarenbeek N; Benninga MA; Savelkoul PHM; de Meij T; Plötz FB
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):231-242. PubMed ID: 32155096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.